-Livemint.com Haryana’s sex ratio at birth is at 903, a first in a decade, but the scheme has made no impact in certain parts Rohtak (Haryana): On 22 January last year, Prime Minister Narendra Modi launched the Beti Bachao, Beti Padhao (save the daughter, educate the daughter) campaign to improve India’s child sex ratio and promote gender equality. Appropriately enough, he flagged off the campaign in Panipat, Haryana, which had the worst...
More »SEARCH RESULT
Community kitchens: An idea whose time has come -Reetika Khera
-Scroll.in Institutions that provide cheap or free meals are not mere populism – they are vital for the food security of people on the margins. My first experience of a “community kitchen” was in Brazil where we were taken to try out a meal at the Popular Restaurant in Lauros de Freitas. The serpentine queue outside it surprising initially, seemed entirely unexceptional once we had been served: for one real (approximately Rs...
More »Child stunting declines, but still high, data show -Rukmini S & Samarth Bansal
-The Hindu As of 2005-06, India had 62 million stunted children, accounting for a third of the world’s burden of stunting. Indian states have seen some improvements in child nutrition over the last decade, the first official data in over a decade shows, but over one in three children is still stunted, and over one in five underweight. As of 2005-6, India had 62 million stunted children, accounting for a third of the...
More »The case for going universal -Diane Coffey & Payal Hathi
-The Hindu Maternity entitlements are an important policy tool for encouraging better maternal health. This is why we need to do away with conditionality in cash transfer schemes Since the National Food Security Act (NFSA) was passed in 2013, policy circles have been buzzing with talk of reforms in the public distribution system (PDS). Less well appreciated is the NFSA’s potential to call attention to, and help address, poor maternal nutrition — an aspect...
More »New diabetes drug cuts cost by 80%
-The Times of India MUMBAI: Diabetics in the country have something to cheer about. A completely new drug in the 'gliptin' family has disrupted the anti-diabetes market by lowering the cost of therapy for patients by 80%. With the launch of the teneligliptin molecule, the popular gliptin category has witnessed a price erosion of over 80% in the last six months, bringing down the cost for a day's treatment from Rs...
More »